Previous studies using neonatal myocytes, animals models, and transgenic mice indicate that PKC β isoforms, particularly βII, also are key mediators in the pathophysiology of cardiac hypertrophy and heart failure [12,26]. This evidence concerns the gene PRKCB and cardiac hypertrophy.